Introduction of the PRACTICE into clinical practice leads to lower hospitalization rates without compromising clinical outcome, and lower medical costs.
ID
Bron
Verkorte titel
Aandoening
Urinary tract infections, urosepsis, acute pyelonefritis, acute prostatitis.
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
- Primary hospital admission rate.<br>
- Secondary hospital admission rate defined as the percentage of patients who need to be hospitalized after initially being treated at home.
Doel van het onderzoek
Introduction of the PRACTICE into clinical practice leads to lower hospitalization rates without compromising clinical outcome, and lower medical costs.
Onderzoeksopzet
Day 0, 2-4, 24-32 and 84-98.
Onderzoeksproduct en/of interventie
Use of the PRACTICE to guide physicians, summing the points for each characteristic: age in years (females age-10); nursing home resident +10; malignancy +30; liver cirrhosis +20; congestive heart failure +10; cerebrovascular disease +10; renal disease +10; altered mental status +20; respiratory rate ¡Ý 30/min +20; systolic blood pressure <90 mmHg +20;
pulse rate >124/min +10; temperature >39.9 C +15. Recommendations: <75 points: strongly recommendation towards home-based management; 75-100 points: consider home-based management; >100 points: strongly recommendation towards hospital admission.
Publiek
Dept. of Infectious Diseases, C5P
PO Box 9600
J.E. Stalenhoef
Leiden 2300 RC
The Netherlands
J.E. Stalenhoef@lumc.nl
Wetenschappelijk
Dept. of Infectious Diseases, C5P
PO Box 9600
J.E. Stalenhoef
Leiden 2300 RC
The Netherlands
J.E. Stalenhoef@lumc.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Competent patient aged 18 years or above;
2. One or more symptom(s) suggestive of urinary tract infection (dysuria, frequency or urgency*; perineal or suprapubic pain; costo-vertebral tenderness or flank pain);
3. Fever(ear or rectal temp of 38.2 C or higher, or axillary temp of 38 C or higher), or history of feeling feverish with shivering or rigors in the past 24 hours;
4. Positive urine nitrate test and/or leucocyturia as depicted by positive leukocyte esterase test or microscopy.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Known allergy to fluoroquinolones;
2. Female patients who are pregnant or lactating;
3. Patients with known polycystic kidney disease;
4. Patients on permanent renal replacement therapy (hemodialysis or peritoneal dialysis);
5. Patients with history of kidney transplantation;
6. Residence outside country of enrolment;
7. Inability to speak or read Dutch;
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL4340 |
| NTR-old | NTR4480 |
| CCMO | NL35220.058.11 |
| OMON | NL-OMON41359 |